Carlos Felipe Cavalcanti Carvalho
Research Subjects
Carlos Felipe Cavalcanti Carvalho has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- João Mauricio Castaldelli-Maia
Departamento de Psiquiatria, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, Brazil
5 shared publications - Arthur Guerra de Andrade
University of São Paulo, Brazil
3 shared publications - Fernanda Piotto Frallonardo
Municipal University of Sao Caetano do Sul (USCS), Sao Caetano do Sul, SP,Brazil
3 shared publications - Julio Torales
Universidad Nacional de Asunción, San Lorenzo, Paraguay
3 shared publications Aline Rodrigues Loreto
Departamento de Neurociência Faculdade de Medicina Centro Universitário FMABC Santo André SP Brazil Departamento de Neurociência, Faculdade de Medicina, Centro Universitário FMABC, Santo André, SP, Brazil
2 shared publications- Antonio Ventriglio
Department of Clinical and Experimental Medicine, University of Foggia, Italy
2 shared publications
Latest Publications
- Open Access
- 1 January 2023
- Published by EDITORA SCIENTIFIC in Trends in Psychiatry and Psychotherapy
- Vol. 45
Sex differences in smoking cessation: a retrospective cohort study in a psychosocial care unit in Brazil
Despite the results of epidemiological and psychometric studies reporting comparable levels of tobacco dependence among males and females, some clinical studies have detected disparities. Some smoking cessation studies based on clinical setting programs reported poorer outcomes among women than men. This retrospective cohort study aimed to compare treatment success and retention between men and women on a smoking cessation program (n = 1,014) delivered at a CAPS-AD unit in Brazil. The psychological intervention lasted 6 weeks for each group of 15 patients. Each patient had to participate in weekly group cognitive-behavioral therapy (CBT) sessions and individual medical appointments during this period. These appointments were focused on the possibility of prescribing pharmacological treatment (i.e., nicotine replacement therapy, bupropion, or nortriptyline) as adjuvants to group therapy. The women had lower smoking severity at baseline, more clinical symptoms, and lower prevalence of alcohol and drug use disorders and were older than the men. Females had significantly higher levels of success (36.6% vs. 29.7%) and retention (51.6% vs. 41.4%) than males. Sensitivity analysis showed that female gender was significantly associated with both retention and success, among those without drug use disorders only. Depending on the smoking cessation setting (i.e., low and middle-income countries and mental health and addiction care units), females can achieve similar and even higher quit rates than males. Previous drug use disorder was an important confounding variable in the gender outcomes analyses. Future studies should try to replicate these positive smoking cessation effects of CBT-based group therapy plus pharmacotherapy in women.
- 1 January 2023
- Published by EDITORA SCIENTIFIC in Trends in Psychiatry and Psychotherapy
- Vol. 45
Open AccessSex differences in smoking cessation: a retrospective cohort study in a psychosocial care unit in Brazil
Despite the results of epidemiological and psychometric studies reporting comparable levels of tobacco dependence among males and females, some clinical studies have detected disparities. Some smoking cessation studies based on clinical setting programs reported poorer outcomes among women than men. This retrospective cohort study aimed to compare treatment success and retention between men and women on a smoking cessation program (n = 1,014) delivered at a CAPS-AD unit in Brazil. The psychological intervention lasted 6 weeks for each group of 15 patients. Each patient had to participate in weekly group cognitive-behavioral therapy (CBT) sessions and individual medical appointments during this period. These appointments were focused on the possibility of prescribing pharmacological treatment (i.e., nicotine replacement therapy, bupropion, or nortriptyline) as adjuvants to group therapy. The women had lower smoking severity at baseline, more clinical symptoms, and lower prevalence of alcohol and drug use disorders and were older than the men. Females had significantly higher levels of success (36.6% vs. 29.7%) and retention (51.6% vs. 41.4%) than males. Sensitivity analysis showed that female gender was significantly associated with both retention and success, among those without drug use disorders only. Depending on the smoking cessation setting (i.e., low and middle-income countries and mental health and addiction care units), females can achieve similar and even higher quit rates than males. Previous drug use disorder was an important confounding variable in the gender outcomes analyses. Future studies should try to replicate these positive smoking cessation effects of CBT-based group therapy plus pharmacotherapy in women.
- 1 November 2021
- Published by Bentham Science Publishers Ltd. in Current Drug Research Reviews
- Vol. 13 (3) , 236-245
Effect of BMI on Prolonged Abstinence after Smoking Cessation Treatment: A Retrospective Cohort Study
Background: Despite the well-documented relationship between weight gain and poorer cessation outcomes among smokers, the role of the former (baseline) weight in smoking cessation is insufficiently investigated. We hypothesized that patients with higher baseline body mass index( BMI) have a worse prognosis in tobacco cessation. Objectives: This retrospective clinical cohort study aimed to investigate the role of the baseline BMI on abstinence over 12 months after participation in smoking cessation treatment conducted in a middle-income country (n = 664). Methods: Data from a 6-week smoking cessation protocol performed in a Psychosocial Care Unit (CAPS) were used. The protocol included four medical consultations and six Cognitive-Behavioral Therapy (CBT) group sessions. Initially, 1,213 participants were evaluated for the study, but only the participants whose telephone contact was successful were included in the outcome analyses. The attrition rate was 45.3%. Continuous and categorical (normal, overweight, and obesity) BMI values were computed. Survival regression models were used to test the associations between BMI and the 12-month abstinence outcome. Self-report 4-week abstinence at the end of treatment was also investigated using logistic regression models. Results: Baseline BMI had no significant effect on both short (4-week-point abstinence) and long (12-month prolonged abstinence) treatment outcomes. Conclusion: The possible influence of the baseline BMI on smoking cessation outcomes, especially considering prolonged abstinence, was not corroborated by our results. Regardless of our results, the detrimental health outcomes due to the combination of obesity/overweight and smoking justify that these subgroups of individuals be continuously targeted for adequate smoking prevention and treatment.
- 1 November 2021
- Published by Bentham Science Publishers Ltd. in Current Drug Research Reviews
- Vol. 13 (3) , 236-245
Effect of BMI on Prolonged Abstinence after Smoking Cessation Treatment: A Retrospective Cohort Study
Background: Despite the well-documented relationship between weight gain and poorer cessation outcomes among smokers, the role of the former (baseline) weight in smoking cessation is insufficiently investigated. We hypothesized that patients with higher baseline body mass index( BMI) have a worse prognosis in tobacco cessation. Objectives: This retrospective clinical cohort study aimed to investigate the role of the baseline BMI on abstinence over 12 months after participation in smoking cessation treatment conducted in a middle-income country (n = 664). Methods: Data from a 6-week smoking cessation protocol performed in a Psychosocial Care Unit (CAPS) were used. The protocol included four medical consultations and six Cognitive-Behavioral Therapy (CBT) group sessions. Initially, 1,213 participants were evaluated for the study, but only the participants whose telephone contact was successful were included in the outcome analyses. The attrition rate was 45.3%. Continuous and categorical (normal, overweight, and obesity) BMI values were computed. Survival regression models were used to test the associations between BMI and the 12-month abstinence outcome. Self-report 4-week abstinence at the end of treatment was also investigated using logistic regression models. Results: Baseline BMI had no significant effect on both short (4-week-point abstinence) and long (12-month prolonged abstinence) treatment outcomes. Conclusion: The possible influence of the baseline BMI on smoking cessation outcomes, especially considering prolonged abstinence, was not corroborated by our results. Regardless of our results, the detrimental health outcomes due to the combination of obesity/overweight and smoking justify that these subgroups of individuals be continuously targeted for adequate smoking prevention and treatment.
- Open Access
- 29 July 2019
- Published by FapUNIFESP (SciELO) in Sao Paulo Medical Journal
- Vol. 137 (3) , 234-240
Experimentation with tobacco during adolescence as a factor influencing treatment of smoking in adulthood. A retrospective cohort
There are still few studies on predictors of smoking cessation in Brazilian samples. Experimentation with tobacco during adolescence (ETA) may be one of the important predictors. This study aimed, within the context of a treatment-seeking group of subjects, to test the hypothesis that ETA negatively affects the outcome of smoking cessation during adulthood. Retrospective (historic) cohort study conducted at a psychosocial care center in São Paulo, Brazil, between 2007 and 2010. Data on sociodemographics, smoking and medical profiles were obtained through self-report questionnaires that were completed at the baseline and at any follow-up appointment. Logistic regression models were constructed to describe factors associated with the outcome of smoking cessation, measured according to the self-reported four-week success rate among 367 outpatient smokers. ETA was found to be associated with not quitting smoking through the treatment (odds ratio = 0.57; 95% confidence interval = 0.33-0.96; P < 0.05), even after adjustment for dependence level, sociodemographics, nicotine patch use and number of years of smoking. Early exposure to nicotine may lead to higher risk of continuing smoking after treatment, in adulthood.
- 29 July 2019
- Published by FapUNIFESP (SciELO) in Sao Paulo Medical Journal
- Vol. 137 (3) , 234-240
Open AccessExperimentation with tobacco during adolescence as a factor influencing treatment of smoking in adulthood. A retrospective cohort
There are still few studies on predictors of smoking cessation in Brazilian samples. Experimentation with tobacco during adolescence (ETA) may be one of the important predictors. This study aimed, within the context of a treatment-seeking group of subjects, to test the hypothesis that ETA negatively affects the outcome of smoking cessation during adulthood. Retrospective (historic) cohort study conducted at a psychosocial care center in São Paulo, Brazil, between 2007 and 2010. Data on sociodemographics, smoking and medical profiles were obtained through self-report questionnaires that were completed at the baseline and at any follow-up appointment. Logistic regression models were constructed to describe factors associated with the outcome of smoking cessation, measured according to the self-reported four-week success rate among 367 outpatient smokers. ETA was found to be associated with not quitting smoking through the treatment (odds ratio = 0.57; 95% confidence interval = 0.33-0.96; P < 0.05), even after adjustment for dependence level, sociodemographics, nicotine patch use and number of years of smoking. Early exposure to nicotine may lead to higher risk of continuing smoking after treatment, in adulthood.
- Open Access
- 1 December 2013
- Published by EDITORA SCIENTIFIC in Brazilian Journal of Psychiatry
- Vol. 35 (4) , 338-346
Outcome predictors of smoking cessation treatment provided by an addiction care unit between 2007 and 2010
Key words: Tobacco; treatment; psychiatric patients; alcohol; group therapy; CBT
- 1 December 2013
- Published by EDITORA SCIENTIFIC in Brazilian Journal of Psychiatry
- Vol. 35 (4) , 338-346
Open AccessOutcome predictors of smoking cessation treatment provided by an addiction care unit between 2007 and 2010
Key words: Tobacco; treatment; psychiatric patients; alcohol; group therapy; CBT